With one of every four deaths in the U.S. being attributed to cancer, it is the second leading cause of death, surpassed only by heart disease. There are more deaths from lung cancer than from any other type of cancer accounting for more than 155,000 deaths annually.
While new lung cancer screening guidelines were available, few providers were compliant with the guidelines, or fully understood the complex reimbursement requirements, particularly the patient characteristics that qualify a patient to be eligible for low-dose computed tomography (LDCT) screening and the documentation required for reimbursement.
Mission Health, based in Asheville, North Carolina, is the state’s sixth largest health system with six hospitals and numerous outpatient and surgery centers. The organization wanted to increase the number of patients screened for lung cancer to catch the disease at an earlier, more treatable phase. Mission established a care process model improvement team, enhanced its screening program, and utilized its analytics platform to extract and integrate data from various source systems to evaluate the impact of LDCT screening and outcomes for its patients. Results from the enhanced program include:
71 percent relative increase in LDCT screening for people at increased risk for lung cancer.
56 people with lung cancer identified through early screening.
4.3 percent relative increase in people being diagnosed at early stage I or II lung cancer.
21.2 percent relative reduction in people diagnosed with late stage III or IV lung cancer.